TY - JOUR
T1 - Preparing accessible and understandable clinical research participant information leaflets and consent forms
T2 - a set of guidelines from an expert consensus conference
AU - Coleman, Eleanor
AU - O’Sullivan, Lydia
AU - Crowley, Rachel
AU - Hanbidge, Moira
AU - Driver, Seán
AU - Kroll, Thilo
AU - Kelly, Aoife
AU - Nichol, Alistair
AU - McCarthy, Orlaith
AU - Sukumar, Prasanth
AU - Doran, Peter
N1 - Funding Information:
The authors are grateful to all of the participants in this Expert Consensus Conference. The authors also thank the Health Research Board-Trials Methodology Research Network, the Irish Platform for Patients? Organisations Science and Industry, the National Adult Literacy Agency, the UCD Clinical Research Centre and the Saint Vincent?s University Hospital Medical Research and Ethics Committee for their support of this project.
Publisher Copyright:
© 2021, The Author(s).
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021
Y1 - 2021
N2 - Background: In line with Good Clinical Practice and the Declaration of Helsinki, it is the investigator’s responsibility to ensure that research participants are sufficiently informed, to enable the provision of informed consent. The Participant Information Leaflet/Informed Consent Form is key to facilitating this communication process. Although studies have indicated that clinical research Participant Information Leaflets/Informed Consent Forms are not optimal in terms of accessibility, there is little or no specific guidance available. The aim of this research was to propose and agree a set of guidelines for academic researchers and sponsors for preparing accessible and understandable Participant Information Leaflets/Informed Consent Forms. Methods: A literature review identified guidance for the preparation of patient-facing documents. Following critical appraisal, key recommendations were extracted and a set of recommendations which can be applied to clinical research Participant Information Leaflets/Informed Consent Forms were prepared. These recommendations were evaluated and amended by an Expert Consensus Conference consisting of a group of key stakeholders. The stakeholders included members of a Research Ethics Committee (both lay and expert), a patient advocate, experienced clinical researchers, a plain English editor and a Data Protection Officer. Consensus was reached regarding a final set of recommendations. Results: 44 recommendations were agreed upon and grouped into five categories: Layout, Formatting, Content, Language and Confirming Readability. These recommendations aimed to maximize accessibility for lay participants, including readers with dyslexia, literacy or numeracy challenges, thereby improving the quality of the consent process. Conclusions: More empirical research is needed to further improve the informed consent process for research participants. However, these recommendations are informed by the current literature and have been ratified by expert stakeholders. It is hoped that these recommendations will help investigators and sponsors to consistently and efficiently produce more accessible clinical research Participant Information Leaflets/Informed Consent Forms.
AB - Background: In line with Good Clinical Practice and the Declaration of Helsinki, it is the investigator’s responsibility to ensure that research participants are sufficiently informed, to enable the provision of informed consent. The Participant Information Leaflet/Informed Consent Form is key to facilitating this communication process. Although studies have indicated that clinical research Participant Information Leaflets/Informed Consent Forms are not optimal in terms of accessibility, there is little or no specific guidance available. The aim of this research was to propose and agree a set of guidelines for academic researchers and sponsors for preparing accessible and understandable Participant Information Leaflets/Informed Consent Forms. Methods: A literature review identified guidance for the preparation of patient-facing documents. Following critical appraisal, key recommendations were extracted and a set of recommendations which can be applied to clinical research Participant Information Leaflets/Informed Consent Forms were prepared. These recommendations were evaluated and amended by an Expert Consensus Conference consisting of a group of key stakeholders. The stakeholders included members of a Research Ethics Committee (both lay and expert), a patient advocate, experienced clinical researchers, a plain English editor and a Data Protection Officer. Consensus was reached regarding a final set of recommendations. Results: 44 recommendations were agreed upon and grouped into five categories: Layout, Formatting, Content, Language and Confirming Readability. These recommendations aimed to maximize accessibility for lay participants, including readers with dyslexia, literacy or numeracy challenges, thereby improving the quality of the consent process. Conclusions: More empirical research is needed to further improve the informed consent process for research participants. However, these recommendations are informed by the current literature and have been ratified by expert stakeholders. It is hoped that these recommendations will help investigators and sponsors to consistently and efficiently produce more accessible clinical research Participant Information Leaflets/Informed Consent Forms.
KW - Clinical research
KW - Clinical trials
KW - Informed consent
KW - Participant information leaflets
KW - Patient and public involvement
KW - Patient information leaflets
UR - http://www.scopus.com/inward/record.url?scp=85106327893&partnerID=8YFLogxK
U2 - 10.1186/s40900-021-00265-2
DO - 10.1186/s40900-021-00265-2
M3 - Article
C2 - 34006326
AN - SCOPUS:85106327893
SN - 2056-7529
VL - 7
JO - Research Involvement and Engagement
JF - Research Involvement and Engagement
IS - 1
M1 - 31
ER -